Oligosaccharide binding proteins from bifidobacterium longum subsp. infantis reveal a preference for host glycans

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Garrido, Daniel ^a   Kim, Jae Han ^a   German, J Bruce ^a   Raybould, Helen E ^a   Mills, David A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GLYCAN; INULIN; MUCIN; OLIGOMER; OLIGOSACCHARIDE; OLIGOSACCHARIDE BINDING PROTEIN; PREBIOTIC AGENT; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; CELL SURFACE RECEPTOR; POLYSACCHARIDE; SACCHARIDE BINDING PROTEINS; SACCHARIDE-BINDING PROTEINS;

ARTICLE; BIFIDOBACTERIUM LONGUM INFANTIS; BINDING AFFINITY; BLOOD GROUP; BREAST MILK; FORAGING; FUCOSYLATION; GENE SEQUENCE; HOST; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; BIFIDOBACTERIUM; CELL STRAIN CACO 2; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; EPITHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; PROTEOMICS;

BIFIDOBACTERIUM LONGUM; MAMMALIA;

BACTERIAL PROTEINS; BIFIDOBACTERIUM; CACO-2 CELLS; EPITHELIAL CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; INULIN; MICROSCOPY, CONFOCAL; MILK, HUMAN; OLIGOSACCHARIDES; POLYSACCHARIDES; PREBIOTICS; PROTEIN BINDING; PROTEOMICS; RECEPTORS, CELL SURFACE;

EID: 79952636140     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017315     Document Type: Article

References (72)

1. Schell MA, Karmirantzou M, Snel B, Vilanova D, Berger B, et al. (2002) The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proc Natl Acad Sci U S A 99: 14422-14427.
2. Xu J, Bjursell MK, Himrod J, Deng S, Carmichael LK, et al. (2003) A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 299: 2074-2076.
3. Tam R, Saier MH Jr, (1993) Structural, functional, and evolutionary relationships among extracellular solute-binding receptors of bacteria. Microbiol Rev 57: 320-346.
4. Haarman M, Knol J, (2005) Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 71: 2318-2324.
5. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. (2005) Diversity of the human intestinal microbial flora. Science 308: 1635-1638.
6. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB, (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17: 259-275.
7. Bouhnik Y, Raskine L, Simoneau G, Paineau D, Bornet F, (2006) The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans. Nutr J 5: 8.
8. Barboza M, Sela DA, Pirim C, Locascio RG, Freeman SL, et al. (2009) Glycoprofiling bifidobacterial consumption of galacto-oligosaccharides by mass spectrometry reveals strain-specific, preferential consumption of glycans. Appl Environ Microbiol 75: 7319-7325.
9. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, et al. (2009) Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101: 541-550.
10. Favier CF, de Vos WM, Akkermans AD, (2003) Development of bacterial and bifidobacterial communities in feces of newborn babies. Anaerobe 9: 219-229.
11. Kleessen B, Bunke H, Tovar K, Noack J, Sawatzki G, (1995) Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediatr 84: 1347-1356.
12. Adlerberth I, Wold AE, (2009) Establishment of the gut microbiota in Western infants. Acta Paediatr 98: 229-238.
13. Ventura M, Elli M, Reniero R, Zink R, (2001) Molecular microbial analysis of Bifidobacterium isolates from different environments by the species-specific amplified ribosomal DNA restriction analysis (ARDRA). FEMS Microbiol Ecol 36: 113-121.
14. Ventura M, O'Connell-Motherway M, Leahy S, Moreno-Munoz JA, Fitzgerald GF, et al. (2007) From bacterial genome to functionality; case bifidobacteria. Int J Food Microbiol 120: 2-12.
15. Kunz C, Rudloff S, Baier W, Klein N, Strobel S, (2000) Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr 20: 699-722.
16. Ninonuevo MR, Park Y, Yin H, Zhang J, Ward RE, et al. (2006) A strategy for annotating the human milk glycome. J Agric Food Chem 54: 7471-7480.
17. Finne J, Breimer ME, Hansson GC, Karlsson KA, Leffler H, et al. (1989) Novel polyfucosylated N-linked glycopeptides with blood group A, H, X, and Y determinants from human small intestinal epithelial cells. J Biol Chem 264: 5720-5735.
18. Wu AM, (2003) Carbohydrate structural units in glycoproteins and polysaccharides as important ligands for Gal and GalNAc reactive lectins. J Biomed Sci 10: 676-688.
19. Podolsky DK, (1985) Oligosaccharide structures of isolated human colonic mucin species. J Biol Chem 260: 15510-15515.
20. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB, (2007) In vitro fermentability of human milk oligosaccharides by several strains of bifidobacteria. Mol Nutr Food Res 51: 1398-1405.
21. Kitaoka M, Tian J, Nishimoto M, (2005) Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum. Appl Environ Microbiol 71: 3158-3162.
22. Ashida H, Miyake A, Kiyohara M, Wada J, Yoshida E, et al. (2009) Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 19: 1010-1017.
23. Nishimoto M, Kitaoka M, (2007) Identification of N-acetylhexosamine 1-kinase in the complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum. Appl Environ Microbiol 73: 6444-6449.
24. LoCascio RG, Ninonuevo MR, Freeman SL, Sela DA, Grimm R, et al. (2007) Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem 55: 8914-8919.
25. Turroni F, Bottacini F, Foroni E, Mulder I, Kim JH, et al. (2010) Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc Natl Acad Sci U S A 107: 19514-19519.
26. Zivkovic AM, German JB, Lebrilla CB, Mills DA, (2010) Microbes and Health Sackler Colloquium: Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A in press.
27. Sela DA, Chapman J, Adeuya A, Kim JH, Chen F, et al. (2008) The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc Natl Acad Sci U S A 105: 18964-18969.
28. Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, et al. (2004) Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A 101: 17033-17038.
29. Hakomori SI, (2008) Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. Biochim Biophys Acta 1780: 325-346.
30. Holgersson J, Jovall PA, Breimer ME, (1991) Glycosphingolipids of human large intestine: detailed structural characterization with special reference to blood group compounds and bacterial receptor structures. J Biochem 110: 120-131.
31. Morgan WT, Watkins WM, (1969) Genetic and biochemical aspects of human blood-group A-, B-, H-, Le-a- and Le-b-specificity. Br Med Bull 25: 30-34.
32. Kogelberg H, Piskarev VE, Zhang Y, Lawson AM, Chai W, (2004) Determination by electrospray mass spectrometry and 1H-NMR spectroscopy of primary structures of variously fucosylated neutral oligosaccharides based on the iso-lacto-N-octaose core. Eur J Biochem 271: 1172-1186.
33. Keranen A, (1975) Gangliosides of the human gastrointestinal mucosa. Biochim Biophys Acta 409: 320-328.
34. Krivan HC, Clark GF, Smith DF, Wilkins TD, (1986) Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3 Gal beta 1-4GlcNAc. Infect Immun 53: 573-581.
35. Asakuma S, Akahori M, Kimura K, Watanabe Y, Nakamura T, et al. (2007) Sialyl oligosaccharides of human colostrum: changes in concentration during the first three days of lactation. Biosci Biotechnol Biochem 71: 1447-1451.
36. Hakomori S, (1999) Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta 1473: 247-266.
37. Parche S, Amon J, Jankovic I, Rezzonico E, Beleut M, et al. (2007) Sugar transport systems of Bifidobacterium longum NCC2705. J Mol Microbiol Biotechnol 12: 9-19.
38. Larson G, Watsfeldt P, Falk P, Leffler H, Koprowski H, (1987) Fecal excretion of intestinal glycosphingolipids by newborns and young children. FEBS Lett 214: 41-44.
39. Ruas-Madiedo P, Gueimonde M, Fernandez-Garcia M, de los Reyes-Gavilan CG, Margolles A, (2008) Mucin degradation by Bifidobacterium strains isolated from the human intestinal microbiota. Appl Environ Microbiol 74: 1936-1940.
40. Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, et al. (2008) Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl Environ Microbiol 74: 3996-4004.
41. Sela DA, Mills DA, (2010) Nursing our microbiota: molecular linkages between bifidobacteria and milk oligosaccharides. Trends Microbiol 18: 298-307.
42. Locascio RG, Desai P, Sela DA, Weimer B, Mills DA, (2010) Broad conservation of milk utilization genes in Bifidobacterium longum subsp. infantis as revealed by comparative genomic hybridization. Appl Environ Microbiol 76: 7373-7381.
43. Suzuki R, Wada J, Katayama T, Fushinobu S, Wakagi T, et al. (2008) Structural and thermodynamic analyses of solute-binding Protein from Bifidobacterium longum specific for core 1 disaccharide and lacto-N-biose I. J Biol Chem 283: 13165-13173.
44. Gonzalez R, Klaassens ES, Malinen E, de Vos WM, Vaughan EE, (2008) Differential transcriptional response of Bifidobacterium longum to human milk, formula milk, and galactooligosaccharide. Appl Environ Microbiol 74: 4686-4694.
45. Xiao JZ, Takahashi S, Nishimoto M, Odamaki T, Yaeshima T, et al. (2010) Distribution of in vitro fermentation ability of lacto-N-biose I, a major building block of human milk oligosaccharides, in bifidobacterial strains. Appl Environ Microbiol 76: 54-59.
46. Miwa M, Horimoto T, Kiyohara M, Katayama T, Kitaoka M, et al. (2010) Cooperation of {beta}-galactosidase and {beta}-N-acetylhexosaminidase from bifidobacteria in assimilation of human milk oligosaccharides with type 2 structure. Glycobiology 20: 1402-1409.
47. Coppa GV, Zampini L, Galeazzi T, Facinelli B, Ferrante L, et al. (2006) Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli, Vibrio cholerae, and Salmonella fyris. Pediatr Res 59: 377-382.
48. Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS, (2003) Campylobacter jejuni binds intestinal H(O) antigen (Fuc alpha 1, 2 Gal beta 1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem 278: 14112-14120.
49. Chaturvedi P, Warren CD, Altaye M, Morrow AL, Ruiz-Palacios G, et al. (2001) Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation. Glycobiology 11: 365-372.
50. Guglielmetti S, Tamagnini I, Mora D, Minuzzo M, Scarafoni A, et al. (2008) Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl Environ Microbiol 74: 4695-4702.
51. Higgins MA, Abbott DW, Boulanger MJ, Boraston AB, (2009) Blood group antigen recognition by a solute-binding protein from a serotype 3 strain of Streptococcus pneumoniae. J Mol Biol 388: 299-309.
52. O'Hara AM, O'Regan P, Fanning A, O'Mahony C, Macsharry J, et al. (2006) Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology 118: 202-215.
53. Candela M, Perna F, Carnevali P, Vitali B, Ciati R, et al. (2008) Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int J Food Microbiol 125: 286-292.
54. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, et al. (2008) Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295: G1025-1034.
55. Holgersson J, Stromberg N, Breimer ME, (1988) Glycolipids of human large intestine: difference in glycolipid expression related to anatomical localization, epithelial/non-epithelial tissue and the ABO, Le and Se phenotypes of the donors. Biochimie 70: 1565-1574.
56. Macher BA, Klock JC, (1980) Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils. J Biol Chem 255: 2092-2096.
57. Miller-Podraza H, Lanne B, Angstrom J, Teneberg S, Milh MA, et al. (2005) Novel binding epitope for Helicobacter pylori found in neolacto carbohydrate chains: structure and cross-binding properties. J Biol Chem 280: 19695-19703.
58. Orlandi PA, Critchley DR, Fishman PH, (1994) The heat-labile enterotoxin of Escherichia coli binds to polylactosaminoglycan-containing receptors in CaCo-2 human intestinal epithelial cells. Biochemistry 33: 12886-12895.
59. Newburg DS, Ashkenazi S, Cleary TG, (1992) Human milk contains the Shiga toxin and Shiga-like toxin receptor glycolipid Gb3. J Infect Dis 166: 832-836.
60. Stromberg N, Marklund BI, Lund B, Ilver D, Hamers A, et al. (1990) Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1-4 Gal-containing isoreceptors. EMBO J 9: 2001-2010.
61. Karlsson KA, Larson G, (1981) Molecular characterization of cell surface antigens of fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human O Le(a- -b+) secretor. J Biol Chem 256: 3512-3524.
62. Lindberg AA, Brown JE, Stromberg N, Westling-Ryd M, Schultz JE, et al. (1987) Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem 262: 1779-1785.
63. Falguieres T, Maak M, von Weyhern C, Sarr M, Sastre X, et al. (2008) Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool. Mol Cancer Ther 7: 2498-2508.
64. Kovbasnjuk O, Mourtazina R, Baibakov B, Wang T, Elowsky C, et al. (2005) The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc Natl Acad Sci U S A 102: 19087-19092.
65. McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, et al. (2003) Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52: 975-980.
66. O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, et al. (2005) Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 128: 541-551.
67. Crociani F, Alessandrini A, Mucci MM, Biavati B, (1994) Degradation of complex carbohydrates by Bifidobacterium spp. Int J Food Microbiol 24: 199-210.
68. Lee JH, O'Sullivan DJ, (2010) Genomic insights into bifidobacteria. Microbiol Mol Biol Rev 74: 378-416.
69. Zhang G, Mills DA, Block DE, (2009) Development of chemically defined media supporting high-cell-density growth of lactococci, enterococci, and streptococci. Appl Environ Microbiol 75: 1080-1087.
70. Ward RE, Ninonuevo M, Mills DA, Lebrilla CB, German JB, (2006) In vitro fermentation of breast milk oligosaccharides by Bifidobacterium infantis and Lactobacillus gasseri. Appl Environ Microbiol 72: 4497-4499.
71. Parche S, Beleut M, Rezzonico E, Jacobs D, Arigoni F, et al. (2006) Lactose-over-glucose preference in Bifidobacterium longum NCC2705: glcP, encoding a glucose transporter, is subject to lactose repression. J Bacteriol 188: 1260-1265.
72. Markowitz VM, Korzeniewski F, Palaniappan K, Szeto E, Werner G, et al. (2006) The integrated microbial genomes (IMG) system. Nucleic Acids Res 34: D344-348.